ArticleCurrent computer-aided drug design2025
Detection of Brain Tumor Employing Residual Network-based Optimized Deep Learning.
Article in Current computer-aided drug design, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed, 4 citations in OpenAlex.
- Deep transfer learning based feature fusion model with Bonobo optimization algorithm for enhanced brain tumor segmentation and classification through biomedical imaging.Scientific reports · 2025Article
- Deep learning-driven brain tumor classification and segmentation using non-contrast MRI.Scientific reports · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundDiagnosis and treatment planning play a very vital role in improving the survival of oncological patients. However, there is high variability in the shape, size, and structure of the tumor, making automatic segmentation difficult. The automatic and accurate detection and segmentation methods for brain tumors are proposed in this paper.
methodsA modified ResNet50 model was used for tumor detection, and a ResUNetmodel-based convolutional neural network for segmentation is proposed in this paper. The detection and segmentation were performed on the same dataset consisting of pre-contrast, FLAIR, and postcontrast MRI images of 110 patients collected from the cancer imaging archive. Due to the use of residual networks, the authors observed improvement in evaluation parameters, such as accuracy for tumor detection and dice similarity coefficient for tumor segmentation.
resultsThe accuracy of tumor detection and dice similarity coefficient achieved by the segmentation model were 96.77% and 0.893, respectively, for the TCIA dataset. The results were compared based on manual segmentation and existing segmentation techniques. The tumor mask was also individually compared to the ground truth using the SSIM value. The proposed detection and segmentation models were validated on BraTS2015 and BraTS2017 datasets, and the results were consensus.
conclusionThe use of residual networks in both the detection and the segmentation model resulted in improved accuracy and DSC score. DSC score was increased by 5.9% compared to the UNet model, and the accuracy of the model was increased from 92% to 96.77% for the test set.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.